Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Database: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP).,Gut and Liver

当前位置： X-MOL 学术 › Gut Liver › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Database: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP).
Gut and Liver ( IF 3.4 ) Pub Date : 2021-05-07 , DOI: 10.5009/gnl20306
Jae Seung Kang ₁ , Lydia Mok ₂ , Jin Seok Heo ₃ , In Woong Han ₃ , Sang Hyun Shin ₃ , Yoo-Seok Yoon ₄ , Ho-Seong Han ₄ , Dae Wook Hwang ₅ , Jae Hoon Lee ₅ , Woo Jung Lee ₆ , Sang Jae Park ₇ , Joon Seong Park ₈ , Yonghoon Kim ₉ , Huisong Lee ₁₀ , Young-Dong Yu ₁₁ , Jae Do Yang ₁₂ , Seung Eun Lee ₁₃ , Il Young Park ₁₄ , Chi-Young Jeong ₁₅ , Younghoon Roh ₁₆ , Seong-Ryong Kim ₁₇ , Ju Ik Moon ₁₈ , Sang Kuon Lee ₁₉ , Hee Joon Kim ₂₀ , Seungyeoun Lee ₂₁ , Hongbeom Kim ₂₂ , Wooil Kwon ₂₂ , Chang-Sup Lim ₁ , Jin-Young Jang ₂₂ , Taesung Park ₂

Affiliation

Department of Surgery, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
Department of Statistics and Interdisciplinary Program in Bioinformatics, Seoul National University, Seoul, Korea.
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.
Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang, Korea.
Pancreatobiliary Cancer Clinic, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Department of Surgery, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
Department of Surgery, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea.
Division of HBP Surgery and Liver Transplantation, Department of Surgery, Korea University College of Medicine, Seoul, Korea.
Department of Surgery, Jeonbuk National University Medical School, Jeonju, Korea.
Department of Surgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.
Department of General Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
Department of Surgery, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea.
Department of Surgery, Dong-A University College of Medicine, Busan, Korea.
Department of Surgery, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.
Department of Surgery, Konyang University Hospital, Daejeon, Korea.
Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea.
Department of Surgery, Chonnam National University Hospital, Gwangju, Korea.
Department of Mathematics and Statistics, Sejong University, Seoul, Korea.
Department of Surgery and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

Several prediction models for evaluating the prognosis of nonmetastatic resected pancreatic ductal adenocarcinoma (PDAC) have been developed, and their performances were reported to be superior to that of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system. We developed a prediction model to evaluate the prognosis of resected PDAC and externally validated it with data from a nationwide Korean database.

中文翻译：

使用两个全国性数据库开发和外部验证胰腺癌生存预测模型：监测、流行病学和最终结果 (SEER) 和韩国肿瘤登记系统 - 胆胰 (KOTUS-BP)。

已经开发了几种用于评估非转移性切除胰腺导管腺癌（PDAC）预后的预测模型，据报道其性能优于美国癌症联合委员会（AJCC）第 8 版分期系统。我们开发了一个预测模型来评估切除的 PDAC 的预后，并使用来自韩国全国数据库的数据对其进行外部验证。

更新日期：2021-05-06

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11